Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
Formula 12 Thyroid
No one logged in.

Protocols: Obesity and Overweight

Endocrinologists, Bariatric Surgeons, Internal Medicine and General Medicine

The World Health Organization (WHO) considers obesity to be the global epidemic of the 21st century. It is currently the most common metabolic-nutritional pathology, in both adults and children, beyond its clinical and sociocultural particularities.

In developing countries, obesity is closely related to economic changes in the population: lack of education among parents, maternal obesity and nutritional insecurity in the home have a negative influence when the time comes to define a healthy lifestyle for the family unit.
This disease is defined as an excess of body fat and is particularly dangerous when this fat accumulates centrally in the body.

This has led to the current practice of classifying obesity, particularly its central form, type 2 diabetes and certain dyslipidemias as chronic, noncommunicable diseases (NCDs). Similary, it is recognized that reducing obesity decreases the risk factors for NCDs and improves quality of life, as well as psychological and social well-being.

Protocol 1


To be taken concurrently with the previous treatment. One white capsule in the morning, one red/white capsule during afternoon and one red capsule at night before meals, during 6 months and re-evaluate.


Administer 2 ml daily deep intramuscular injection, during 5 days, rest for 2 days and ad-minister another complete treatment of 2ml daily during 5 days (2 boxes). The treatment should be repeated every 6 months.


2 tablets at morning (fasting), 2 tablets at night (on an empty stomach) Treatment should be taken continuously for at least 3 months, and then re-evaluate.

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.


Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.


This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2021 Biocell Ultravital